What is the recommended laboratory testing sequence for diagnosing hepatitis C (HCV) infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Laboratory Testing Sequence for Hepatitis C Diagnosis

The recommended laboratory testing sequence for diagnosing hepatitis C (HCV) infection is to order HCV-antibody testing with reflex HCV RNA polymerase chain reaction testing for initial HCV screening. 1

Initial Testing Algorithm

  1. First-line test: HCV antibody test

    • Use an FDA-approved assay (laboratory-based or point-of-care)
    • Order as "HCV antibody with reflex to HCV RNA" to avoid requiring a second blood draw 1
    • This approach requires only a single blood collection and prevents loss to follow-up 1
  2. Interpretation of HCV antibody results:

    • Nonreactive: No HCV antibody detected (no current or past infection in most cases)
    • Reactive: Indicates one of three possibilities:
      • Current HCV infection (acute or chronic)
      • Past, resolved HCV infection
      • False positive result 1
  3. Reflex testing for reactive antibody results:

    • All reactive HCV antibody tests should automatically reflex to HCV RNA testing 1
    • HCV RNA testing confirms active infection and distinguishes between current infection and resolved/false positive results

Special Testing Considerations

  • Recent exposure (within 6 months):

    • Consider direct HCV RNA testing or follow-up HCV antibody testing 6+ months after exposure 1
    • HCV antibody may not be detectable during this "window period"
  • Immunocompromised patients:

    • Consider direct HCV RNA testing as these patients may have false-negative antibody results 1, 2
  • Persons at risk for reinfection:

    • Use HCV RNA testing directly (antibody will remain positive from previous infection) 1
  • Distinguishing false positives from resolved infection:

    • If clinically important, consider testing with a second, different HCV antibody assay 1
    • Different assays vary in antigens, platforms, and performance characteristics 1

Pre-Treatment Testing

If HCV RNA is detected (confirming current infection), additional testing is recommended:

  1. Quantitative HCV RNA testing:

    • Documents baseline viral load before starting treatment 1
  2. HCV genotype testing:

    • May be considered if it would alter treatment recommendations 1
  3. Additional recommended tests:

    • Liver function tests (AST/ALT, alkaline phosphatase, bilirubin, albumin)
    • Complete blood count
    • Prothrombin time/INR
    • Testing for coinfections (HBV, HIV) 2

Common Pitfalls to Avoid

  • Incomplete testing: Ordering only HCV antibody without reflex to RNA testing leads to diagnostic delays and loss to follow-up 1

  • Misinterpreting positive antibody tests: A positive antibody test alone doesn't confirm current infection 1

  • Missing acute infections: Relying solely on antibody testing in recently exposed individuals may miss early infections 1

  • Inadequate specimen handling: Improper storage or handling of specimens for HCV RNA testing can lead to false negative results 1

  • Failing to educate patients: Patients with positive antibody but negative RNA should understand they are not currently infected but remain susceptible to reinfection 1

By following this evidence-based testing algorithm, clinicians can accurately diagnose HCV infection, enabling appropriate treatment decisions that reduce morbidity and mortality from chronic hepatitis C.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Hepatitis Immunity Testing

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.